The following study describes a methodology to establish, control, and characterize an aerosolized bioburden within a test chamber and determine the settling rate of the bioburden.
F. Andreas Toba
Advertisement
F. Andreas Toba is Vice President, Intact Pharma Operations, MedInstill Development.
Articles by F. Andreas Toba
Advertisement
Latest Updated Articles
Advertisement
Advertisement